Cross-sectional survey reveals logistics and doctor support drive rheumatology trial enrollment, suggesting improvements for recruitment strategies.
Group-based medical mistrust did not predict self-reported willingness to join a rheumatology clinical trial. Instead, expectation of concrete disease improvement and personal endorsement by one's treating rheumatologist emerged as the strongest drivers of participation. Recruitment strategies that emphasize realistic potential benefits, incorporate physician-delivered invitations, and address logistics may improve enrollment.
No takes yet. Share an insight, caveat, or question.
Paulino et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: